NL300779I2 - Combinatie van a) olodaterol, het individuele optische R-isomeer daarvan, mengsels van individuele enantiomeren of racematen, zuuradditiezouten daarvan met farmacologisch aanvaardbare zuren, desgewenst in de vorm van solvaten en/of hydraten, en b) een tiotropiumzout; in het bijzonder combinatie van a) olodaterol en zuuradditiezouten daarvan met farmacologisch aanvaardbare zuren, en b) tiotropiumbromide, desgewenst in de vorm van een solvaat en/of hydraat; meer in het bijzonder combinatie van a) olodaterolhydrochloride en b) tiotropiumbromide, desgewenst in de vorm van het monohydraat - Google Patents

Combinatie van a) olodaterol, het individuele optische R-isomeer daarvan, mengsels van individuele enantiomeren of racematen, zuuradditiezouten daarvan met farmacologisch aanvaardbare zuren, desgewenst in de vorm van solvaten en/of hydraten, en b) een tiotropiumzout; in het bijzonder combinatie van a) olodaterol en zuuradditiezouten daarvan met farmacologisch aanvaardbare zuren, en b) tiotropiumbromide, desgewenst in de vorm van een solvaat en/of hydraat; meer in het bijzonder combinatie van a) olodaterolhydrochloride en b) tiotropiumbromide, desgewenst in de vorm van het monohydraat

Info

Publication number: NL300779I2
Authority: NL; Netherlands
Prior art keywords: optionally; olodaterol; combination; acid addition; addition salts
Prior art date: 2004-04-22

Application number

NL300779C

Other languages

English (en)

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-22

Filing date

2015-12-01

Publication date

2017-11-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300779(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-04-22 Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de

2004-11-03 Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de

2015-12-01 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2017-11-02 Publication of NL300779I2 publication Critical patent/NL300779I2/nl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

NL300779C 2004-04-22 2015-12-01 Combinatie van a) olodaterol, het individuele optische R-isomeer daarvan, mengsels van individuele enantiomeren of racematen, zuuradditiezouten daarvan met farmacologisch aanvaardbare zuren, desgewenst in de vorm van solvaten en/of hydraten, en b) een tiotropiumzout; in het bijzonder combinatie van a) olodaterol en zuuradditiezouten daarvan met farmacologisch aanvaardbare zuren, en b) tiotropiumbromide, desgewenst in de vorm van een solvaat en/of hydraat; meer in het bijzonder combinatie van a) olodaterolhydrochloride en b) tiotropiumbromide, desgewenst in de vorm van het monohydraat NL300779I2 (nl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE102004019540A DE102004019540A1 (de)	2004-04-22	2004-04-22	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987A DE102004052987A1 (de)	2004-11-03	2004-11-03	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496		2005-02-07
PCT/EP2005/004073 WO2005102349A1 (de)	2004-04-22	2005-04-18	Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen
EP05739576A EP1781298B1 (de)	2004-04-22	2005-04-18	Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen

Publications (1)

Publication Number	Publication Date
NL300779I2 true NL300779I2 (nl)	2017-11-02

Family

ID=34966478

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL300779C NL300779I2 (nl)	2004-04-22	2015-12-01	Combinatie van a) olodaterol, het individuele optische R-isomeer daarvan, mengsels van individuele enantiomeren of racematen, zuuradditiezouten daarvan met farmacologisch aanvaardbare zuren, desgewenst in de vorm van solvaten en/of hydraten, en b) een tiotropiumzout; in het bijzonder combinatie van a) olodaterol en zuuradditiezouten daarvan met farmacologisch aanvaardbare zuren, en b) tiotropiumbromide, desgewenst in de vorm van een solvaat en/of hydraat; meer in het bijzonder combinatie van a) olodaterolhydrochloride en b) tiotropiumbromide, desgewenst in de vorm van het monohydraat

Country Status (31)

Country	Link
EP (2)	EP1781298B1 (nl)
JP (1)	JP2007533683A (nl)
KR (2)	KR101287460B1 (nl)
AR (1)	AR049262A1 (nl)
AT (1)	ATE539754T1 (nl)
AU (1)	AU2005235419B2 (nl)
BR (1)	BRPI0510080B8 (nl)
CA (1)	CA2559699C (nl)
CY (3)	CY1113890T1 (nl)
DK (2)	DK2422786T3 (nl)
EA (1)	EA013157B1 (nl)
EC (1)	ECSP066947A (nl)
ES (2)	ES2380370T3 (nl)
FI (1)	FIC20170005I1 (nl)
HU (1)	HUS1500058I1 (nl)
IL (2)	IL177685A (nl)
LT (1)	LTC1781298I2 (nl)
LU (1)	LU93066I2 (nl)
MY (1)	MY148945A (nl)
NL (1)	NL300779I2 (nl)
NO (2)	NO337714B1 (nl)
NZ (1)	NZ550797A (nl)
PE (1)	PE20060462A1 (nl)
PL (2)	PL2422786T3 (nl)
PT (2)	PT2422786E (nl)
SG (1)	SG152237A1 (nl)
SI (2)	SI1781298T1 (nl)
TW (2)	TWI374739B (nl)
UY (1)	UY28861A1 (nl)
WO (1)	WO2005102349A1 (nl)
ZA (1)	ZA200606624B (nl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024452A1 (de) *	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolformulierung für die Inhalation von Betaagonisten
US7923455B2 (en) *	2005-01-28	2011-04-12	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
JP2008530177A (ja) *	2005-02-16	2008-08-07	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	抗コリン作用薬及びエチプレドノールを含有する医薬組成物
JP5270343B2 (ja)	2005-08-15	2013-08-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ベータミメティックスの製造方法
US20070088030A1 (en)	2005-10-10	2007-04-19	Barbara Niklaus-Humke	Aerosol formulations for the inhalation of beta-agonists
TWI396541B (zh)	2005-10-10	2013-05-21	Boehringer Ingelheim Int	用於治療呼吸疾病之新穎藥物組合
AU2006315657B2 (en) *	2005-11-10	2011-12-01	Shell Internationale Research Maatschappij B.V.	Soft anticholinergic esters
WO2007093608A1 (de) *	2006-02-16	2007-08-23	Boehringer Ingelheim International Gmbh	Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
US20090324510A1 (en)	2006-08-07	2009-12-31	Boehringer Ingelheim International Gmbh	Drug combinations for the treatment of respiratory tract diseases
UY30542A1 (es) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	Formulacion de aerosol para la inhalacion de beta- agonistas
WO2008049842A2 (en) *	2006-10-26	2008-05-02	Boehringer Ingelheim International Gmbh	Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
EP1921070A1 (de)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
WO2009098061A1 (de)	2008-02-07	2009-08-13	Boehringer Ingelheim International Gmbh	Spirocyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
JP5539351B2 (ja)	2008-08-08	2014-07-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	シクロヘキシルオキシ置換ヘテロ環、これらの化合物を含有する医薬、およびそれらを生成するための方法
JP2012509922A (ja) *	2008-11-27	2012-04-26	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規粉末化結晶質吸入薬
WO2014016548A2 (en)	2012-07-27	2014-01-30	Cipla Limited	Pharmaceutical composition
JP2015533131A (ja) *	2012-10-09	2015-11-19	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	咳を治療するためのベータ２−アドレナリン受容体作動薬

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4460581A (en) *	1982-10-12	1984-07-17	Boehringer Ingelheim Kg	(1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
FI88112C (fi)	1985-07-30	1993-04-13	Glaxo Group Ltd	Anordning foer administrering av laekemedel till patienter
SE453566B (sv)	1986-03-07	1988-02-15	Draco Ab	Anordning vid pulverinhalatorer
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
DE4318455A1 (de)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Kapselhalterung
DE19536902A1 (de)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
BR0110331A (pt) *	2000-04-27	2003-01-07	Boehringer Ingelheim Pharma	Substâncias que mimetizam beta que têm uma atividade de longa duração, processos para prepará-las e o uso das mesmas como medicamentos
TR200402579T4 (tr)	2000-10-12	2004-12-21	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Kristalin monohidrat, bunun imalat yöntemi ve bir ilaç maddesinin imalatında kullanımı
SI1401445T1 (sl)	2001-06-22	2007-02-28	Boehringer Ingelheim Pharma	Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila
DE10130371A1 (de) *	2001-06-23	2003-01-02	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) *	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) *	2002-07-09	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) *	2002-10-04	2004-04-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) *	2002-11-15	2004-05-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

2005
- 2005-04-18 SG SG200902525-5A patent/SG152237A1/en unknown
- 2005-04-18 PT PT111870382T patent/PT2422786E/pt unknown
- 2005-04-18 PL PL11187038T patent/PL2422786T3/pl unknown
- 2005-04-18 SI SI200531488T patent/SI1781298T1/sl unknown
- 2005-04-18 CA CA2559699A patent/CA2559699C/en not_active Expired - Fee Related
- 2005-04-18 PT PT05739576T patent/PT1781298E/pt unknown
- 2005-04-18 WO PCT/EP2005/004073 patent/WO2005102349A1/de active Application Filing
- 2005-04-18 AT AT05739576T patent/ATE539754T1/de active
- 2005-04-18 EP EP05739576A patent/EP1781298B1/de active Active
- 2005-04-18 DK DK11187038.2T patent/DK2422786T3/da active
- 2005-04-18 ES ES05739576T patent/ES2380370T3/es active Active
- 2005-04-18 ES ES11187038.2T patent/ES2523518T3/es active Active
- 2005-04-18 JP JP2007508805A patent/JP2007533683A/ja active Pending
- 2005-04-18 NZ NZ550797A patent/NZ550797A/en unknown
- 2005-04-18 SI SI200531904T patent/SI2422786T1/sl unknown
- 2005-04-18 KR KR1020067024528A patent/KR101287460B1/ko active IP Right Grant
- 2005-04-18 DK DK05739576.6T patent/DK1781298T3/da active
- 2005-04-18 KR KR1020137011141A patent/KR20130049840A/ko not_active Application Discontinuation
- 2005-04-18 EP EP11187038.2A patent/EP2422786B1/de active Active
- 2005-04-18 EA EA200601846A patent/EA013157B1/ru active Protection Beyond IP Right Term
- 2005-04-18 AU AU2005235419A patent/AU2005235419B2/en active Active
- 2005-04-18 PL PL05739576T patent/PL1781298T4/pl unknown
- 2005-04-18 BR BRPI0510080A patent/BRPI0510080B8/pt active IP Right Grant
- 2005-04-19 UY UY28861A patent/UY28861A1/es not_active Application Discontinuation
- 2005-04-20 PE PE2005000432A patent/PE20060462A1/es active IP Right Grant
- 2005-04-20 MY MYPI20051739A patent/MY148945A/en unknown
- 2005-04-21 TW TW101108945A patent/TWI374739B/zh active
- 2005-04-21 TW TW094112735A patent/TWI372056B/zh active
- 2005-04-22 AR ARP050101601A patent/AR049262A1/es not_active Application Discontinuation
2006
- 2006-08-08 ZA ZA2006/06624A patent/ZA200606624B/en unknown
- 2006-08-24 IL IL177685A patent/IL177685A/en active IP Right Grant
- 2006-10-23 EC EC2006006947A patent/ECSP066947A/es unknown
- 2006-11-02 NO NO20065060A patent/NO337714B1/no active Protection Beyond IP Right Term
2012
- 2012-03-26 CY CY20121100308T patent/CY1113890T1/el unknown
2013
- 2013-05-26 IL IL226562A patent/IL226562A0/en unknown
2014
- 2014-11-07 CY CY20141100925T patent/CY1115719T1/el unknown
2015
- 2015-12-01 LT LTPA2015043C patent/LTC1781298I2/lt unknown
- 2015-12-01 NL NL300779C patent/NL300779I2/nl unknown
- 2015-12-01 HU HUS1500058C patent/HUS1500058I1/hu unknown
2016
- 2016-05-09 LU LU93066C patent/LU93066I2/fr unknown
- 2016-12-01 NO NO2016022C patent/NO2016022I2/no unknown
2017
- 2017-01-13 FI FIC20170005C patent/FIC20170005I1/fi unknown
- 2017-04-20 CY CY2017014C patent/CY2017014I1/el unknown

Also Published As

Publication number	Publication date
ZA200606624B (en)	2008-01-08
PT2422786E (pt)	2014-11-12
MY148945A (en)	2013-06-14
CY2017014I2 (el)	2017-11-14
IL177685A (en)	2013-10-31
CY1115719T1 (el)	2017-01-25
ECSP066947A (es)	2007-01-26
PL1781298T3 (pl)	2012-06-29
WO2005102349A1 (de)	2005-11-03
DK1781298T3 (da)	2012-05-07
BRPI0510080B1 (pt)	2020-08-18
BRPI0510080A (pt)	2007-10-16
LTC1781298I2 (lt)	2018-09-25
CY1113890T1 (el)	2016-07-27
NZ550797A (en)	2010-08-27
CA2559699A1 (en)	2005-11-03
TWI372056B (en)	2012-09-11
HUS1500058I1 (hu)	2016-01-28
EP1781298A1 (de)	2007-05-09
ES2523518T3 (es)	2014-11-26
PE20060462A1 (es)	2006-06-19
BRPI0510080B8 (pt)	2021-05-25
NO2016022I1 (no)	2016-12-01
PT1781298E (pt)	2012-02-03
AR049262A1 (es)	2006-07-12
PL2422786T3 (pl)	2015-02-27
NO20065060L (no)	2006-11-21
PL1781298T4 (pl)	2017-07-31
ES2380370T3 (es)	2012-05-11
EP2422786A1 (de)	2012-02-29
AU2005235419A1 (en)	2005-11-03
KR20130049840A (ko)	2013-05-14
DK2422786T3 (da)	2014-11-17
SI2422786T1 (sl)	2014-12-31
CA2559699C (en)	2012-06-19
EP2422786B1 (de)	2014-08-13
EA013157B1 (ru)	2010-02-26
EP1781298B1 (de)	2012-01-04
JP2007533683A (ja)	2007-11-22
TWI374739B (en)	2012-10-21
EA200601846A1 (ru)	2007-04-27
NO337714B1 (no)	2016-06-06
FIC20170005I1 (fi)	2017-01-13
UY28861A1 (es)	2005-11-30
SI1781298T1 (sl)	2012-04-30
IL226562A0 (en)	2013-06-27
NO2016022I2 (no)	2016-12-01
KR20070015592A (ko)	2007-02-05
AU2005235419B2 (en)	2010-11-04
LU93066I2 (fr)	2016-07-11
IL177685A0 (en)	2006-12-31
CY2017014I1 (el)	2017-11-14
SG152237A1 (en)	2009-05-29
ATE539754T1 (de)	2012-01-15
KR101287460B1 (ko)	2013-07-23
TW201231055A (en)	2012-08-01

Publication	Publication Date	Title
NL300779I2 (nl)	2017-11-02	Combinatie van a) olodaterol, het individuele optische R-isomeer daarvan, mengsels van individuele enantiomeren of racematen, zuuradditiezouten daarvan met farmacologisch aanvaardbare zuren, desgewenst in de vorm van solvaten en/of hydraten, en b) een tiotropiumzout; in het bijzonder combinatie van a) olodaterol en zuuradditiezouten daarvan met farmacologisch aanvaardbare zuren, en b) tiotropiumbromide, desgewenst in de vorm van een solvaat en/of hydraat; meer in het bijzonder combinatie van a) olodaterolhydrochloride en b) tiotropiumbromide, desgewenst in de vorm van het monohydraat
NO2021018I1 (no)	2021-05-10	kabotegravir eller et farmasøytisk akseptabelt salt eller solvat derav
NL301199I2 (nl)	2023-02-16	Difelikefalin, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, hydraat, solvaat, zuurzout-hydraat of N-oxide
FIC20210010I1 (fi)	2021-05-12	Fedratinibi tai sen farmaseuttisesti hyväksyttävä suola tai sen farmaseuttisesti hyväksyttävä hydraatti, erityisesti fedratinibidihydrokloridimonohydraatti
NL301106I1 (nl)	2021-06-02	Cenobamaat of een farmaceutisch aanvaardbaar zout daarvan
NL300974I2 (nl)	2022-04-06	Binimetinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of solvaat
NL301042I1 (nl)	2020-06-17	Trifaroteen, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
NO2022057I1 (no)	2022-12-13	Capmatinib or a pharmaceutically acceptable salt thereof
FIC20240007I1 (fi)	2024-03-13	Gefapiksantti tai sen farmaseuttisesti hyväksyttävä suola
NL301150I2 (nl)	2022-11-24	setmelanotide, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
NL301037I2 (nl)	2020-05-12	Solriamfetol of een farmaceutisch aanvaardbaar zout daarvan, bij voorkeur het hydrochloridezout daarvan
NL301049I2 (nl)	2020-09-10	crisaborole, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
NL300913I2 (nl)	2017-12-20	Cariprazine, optioneel in de vorm van een zout, waaronder cariprazine hydrochloride
NO2019027I1 (no)	2019-07-04	kobicistat eller et farmasøytisk akseptabelt salt derav
NL300996I2 (nl)	2019-07-30	Naldemedine dan wel een farmaceutisch aanvaardbaar zout of solvaat daarvan, in het bijzonder het tosylaatzout
DK1711481T4 (da)	2013-08-26	Krystallinsk monohydrat som kinaseinhibitorer
IL190198A0 (en)	2008-11-03	N-(3-amino-quinoxalin-2-yl)-sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
ATE488229T1 (de)	2010-12-15	Transdermale verabreichung eines meptazinolsalzes
SMP201000002B (it)	2010-07-13	Sali dell'inibitore di chinasi janus (R)-3-(4-(7H-pirrolo[2,3-D]pirimidin-4-IL)-1H-pirazoli-1-IL)-3-ciclopentilpropanonitrile
DE60330909D1 (de)	2010-02-25	Tablette mit modifizierter freisetzung von bupropion hydrochlorid
RS52743B (en)	2013-08-30	(2S, 3R) -N- (2 - ((3-PYRIDINYL) METHYL) -1-AZABICYCLO [2.2.2] OCT-3-IL) BENZOFURAN-2-CARBOXAMID, NEW FORMS OF SALTS AND PROCEDURES FOR THEIR USE
AR061980A1 (es)	2008-08-10	Acilanilidas sustituidas y metodos para su utilizacion
TW200716567A (en)	2007-05-01	Aspartyl protease inhibitors
DK1789021T3 (da)	2012-03-05	Forlænget-frigivelse-tabletformulering indeholdende pramipexol eller et farmaceutisk acceptabelt salt deraf
PE20080559A1 (es)	2008-05-16	Derivados de heteroaril sustituidos